drugset / Trial / NCT04122040
Effects of Roxithromycin on Quality of Life and Physiological Outcomes in Bronchiectasis
RandomizedParallel-groupSingle-blindTreatment
Summary
roxithormycin 300 mg per day for 12 weeks could improve quality of life and physiological outcomes in bronchiectasis
Timeline
- Start
- 2011-03-01
- Primary completion
- 2011-09-30
- Completion
- 2011-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | roxithromycin | Small molecule | 300 mg | Oral |
Indications
No indication recorded.